BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23389434)

  • 1. Glucagonoma with necrolytic migratory erythema exhibiting responsiveness to subcutaneous octreotide injections.
    Lo CH; Ho CL; Shih YL
    QJM; 2014 Feb; 107(2):157-8. PubMed ID: 23389434
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.
    Oberkirchner U; Linder KE; Zadrozny L; Olivry T
    Vet Dermatol; 2010 Oct; 21(5):510-6. PubMed ID: 20500495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant glucagonoma: an uncommon cause of new onset diabetes].
    Guerrero Vázquez R; Oliva Rodríguez R; Cuenca Cuenca JI; Sánchez Alberdi F; Navarro González E
    Endocrinol Nutr; 2011 Apr; 58(4):199-201. PubMed ID: 21334267
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid improvement of glucagonoma-related necrolytic migratory erythema with octreotide.
    Kimbara S; Fujiwara Y; Toyoda M; Chayahara N; Imamura Y; Kiyota N; Mukohara T; Fukunaga A; Oka M; Nishigori C; Minami H
    Clin J Gastroenterol; 2014 Jun; 7(3):255-9. PubMed ID: 26183746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide-responsive necrolytic migratory erythema in a patient with pseudoglucagonoma syndrome.
    Virani S; Prajapati V; Devani A; Mahmood MN; Elliott JF
    J Am Acad Dermatol; 2013 Feb; 68(2):e44-6. PubMed ID: 23317985
    [No Abstract]   [Full Text] [Related]  

  • 6. [Necrolytic migratory erythema revealing glucagonoma syndrome].
    Maouni S; Elanzi W; Sqalli A; Elmeknassi I; Meziane M; Benzekri L; Hassam B; Senouci K
    Ann Dermatol Venereol; 2019 May; 146(5):419-421. PubMed ID: 30910336
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucagonoma syndrome associated with necrolytic migratory erythema.
    Cardoso Filho Fde A; Feitosa RG; Fechine CO; Matos CM; Cardoso AL; Cardoso DL
    Rev Assoc Med Bras (1992); 2015; 61(3):203-6. PubMed ID: 26248239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrolytic Migratory Erythema Associated with a Glucagonoma.
    Banerjee A; Shah SR
    N Engl J Med; 2020 Aug; 383(6):e39. PubMed ID: 32757527
    [No Abstract]   [Full Text] [Related]  

  • 9. Necrolytic migratory erythema: a common cutaneous clue of uncommon syndromes.
    Stavropoulos PG; Papafragkaki DK; Avgerinou G; Papafragkakis H; Katsavou A; Katsambas AD
    Cutis; 2013 Nov; 92(5):E1-4. PubMed ID: 24343217
    [No Abstract]   [Full Text] [Related]  

  • 10. Normoglycemic glucagonoma syndrome associated with necrolytic migratory erythema.
    Feldmann R; Wahl S; Steiner A
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):e306-e307. PubMed ID: 29419911
    [No Abstract]   [Full Text] [Related]  

  • 11. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
    Tolliver S; Graham J; Kaffenberger BH
    Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Image Gallery: Necrolytic migratory erythema associated with glucagonoma.
    Aragón-Miguel R; Prieto-Barrios M; Calleja-Algarra A; Pinilla-Martin B; Rodriguez-Peralto J; Ortiz-Romero P; Rivera-Diaz R
    Br J Dermatol; 2019 Jan; 180(1):e1. PubMed ID: 30604550
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical response of an atypical glucagonoma treated with a long-acting somatostatin analog].
    Bouin M; Aoust LD
    Gastroenterol Clin Biol; 2002 Oct; 26(10):926-9. PubMed ID: 12434103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine.
    Jiménez-Gallo D; Ossorio-García L; de la Varga-Martínez R; Arjona-Aguilera C; Linares-Barrios M
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508546
    [No Abstract]   [Full Text] [Related]  

  • 15. Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma.
    Boujan N; Géraud C
    Lancet; 2020 Mar; 395(10228):985. PubMed ID: 32199485
    [No Abstract]   [Full Text] [Related]  

  • 16. Pancreatic glucagonoma with pancreatic calcification.
    Gupta RA; Udwadia FE; Agrawal P; Doctor N
    Pancreatology; 2013; 13(3):327-9. PubMed ID: 23719610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagonoma Syndrome: A Rare Paraneoplastic Disorder due to Neuroendocrine Tumor of the Pancreas.
    Yusuf MA; Mehmood S; Iftikhar J; Saqib M; Siddique MZ; Imtiaz W
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):S147-S149. PubMed ID: 36210677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A painful blistering rash on the lower legs and perineum.
    Langan EA; Mansoor W; Brabant G; Jamieson LA; Young HS
    Clin Exp Dermatol; 2013 Mar; 38(2):209-11. PubMed ID: 22548485
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucagonoma syndrome with atypical necrolytic migratory erythema.
    He S; Zeng W; Geng S; Jia J
    Indian J Dermatol Venereol Leprol; 2021; 87(1):49-53. PubMed ID: 31368453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.